GlassScriptPhysician profile
Mike Zuniga
NPI 1578791588
$2,554.02
in general payments reported to CMS, 2019-2025
28 companies · $78.30 in 2025
The $78.30 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $603 · 2020: $19.15 · 2021: $154 · 2022: $179 · 2023: $1,521 · 2025: $78.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $924 · Food and Beverage: $675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $923.73 |
| Food and Beverage | $675.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $1,463.21 | 2022-2023 | Venclose Maven Catheter |
| Abbvie INC. | $229.79 | 2021-2023 | Vraylar |
| Janssen Pharmaceuticals, INC | $107.97 | 2019-2021 | |
| Novo Nordisk INC | $83.38 | 2019-2021 | |
| Abbott Laboratories | $78.30 | 2025 | Freestyle Libre 3 |
| Pfizer INC. | $71.62 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $71.55 | 2019 | |
| Amgen INC. | $46.13 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $41.85 | 2019 | |
| Lilly USA, LLC | $33.40 | 2019-2022 | |
| Mannkind Corporation | $29.54 | 2019 | |
| Glaxosmithkline, LLC. | $28.75 | 2022 | |
| Hologic Sales and Service, LLC | $23.63 | 2023 | Thinprep 2000 Processor, Aptima |
| Amarin Pharma, INC. | $20.61 | 2019 | |
| Endo Pharmaceuticals INC. | $20.22 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $19.15 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $18.87 | 2019 | |
| Lundbeck LLC | $18.65 | 2019 | |
| Sanofi Pasteur INC. | $17.63 | 2019 | |
| Tactile Systems Technology INC | $16.26 | 2023 | Entre Plus, Flexitouch Plus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.17 | 2019 | |
| Esperion Therapeutics, INC. | $16.07 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $15.83 | 2019 | |
| Astellas Pharma US INC | $15.14 | 2019 | |
| Therapeuticsmd, INC. | $13.58 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $13.35 | 2022 | |
| Novartis Pharmaceuticals Corporation | $11.82 | 2019 | |
| Sanofi-Aventis U.S. LLC | $11.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mike Zuniga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.